ScholarLens Back to search
2008•Chinese Journal of ArteriosclerosisRequires access

The Effect of Probucol and Atorvastatin on Success Rate of Blood Lipids and Prognosis in Acute Coronary Syndrome Patients

Yan Song

Open publisher page 0 citations

Abstract

Aim To investigate the influences of probucol combined with atorvastatin and solo atorvastatin on success rate of lipid and prognosis in acute coronary syndrome(ACS) patients at 1 month. Methods Ninety ACS patients were assigned to solo atorvastatin group(20 mg/d atorvastatin for 1 month,n=49) or therapeutic alliance group(20 mg/d atorvastain and 1.0 g/d probucol for 1 month n=41) in a randomized block,controlled study.Serum levels of blood lipids were detected before and aftert teatment.Then prognosis was compared in the two groups. Results The success rate of blood lipids of therapeutic alliance group was higher than solo atorvastatin group,and the prognosis was insignificantly between the two groups. Conclusion Both atorvastatin and probucol may cut down blood lipids in the ACS patients,and atorvastatin combined with probucol can elevate the success rate of blood lipids.

About this research paper

What this paper is about

Aim To investigate the influences of probucol combined with atorvastatin and solo atorvastatin on success rate of lipid and prognosis in acute coronary syndrome(ACS) patients at 1 month. Methods Ninety ACS patients were assigned to solo atorvastatin group(20 mg/d atorvastatin for 1 month,n=49) or therapeutic alliance group(20 mg/d atorvastain and 1.0 g/d probucol for 1 month n=41) in a randomized block,controlled study.Serum levels of blood lipids were detected before and aftert teatment.Then prognosis was compared in the two groups. Results The success rate of blood lipids of therapeutic alliance group was higher than solo atorvastatin group,and the prognosis was insignificantly between the two groups. Conclusion Both atorvastatin and probucol may cut down blood lipids in the ACS patients,and atorvastatin combined with probucol can elevate the success rate of blood lipids.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To investigate the influences of probucol combined with atorvastatin and solo atorvastatin on success rate of lipid and prognosis in acute coronary syndrome(ACS) patients at 1 month. Methods Ninety ACS patients were assigned to solo atorvastatin group(20 mg/d atorvastatin for 1 month,n=49) or therapeutic alliance group(20 mg/d atorvastain and 1.0 g/d probucol for 1 month n=41) in a randomized block,controlled study.Serum levels of blood lipids were detected before and aftert teatment.Then prognosis was compared in the two groups. Results The success rate of blood lipids of therapeutic alliance group was higher than solo atorvastatin group,and the prognosis was insignificantly between the two groups. Conclusion Both atorvastatin and probucol may cut down blood lipids in the ACS patients,and atorvastatin combined with probucol can elevate the success rate of blood lipids.

Key concepts: Atorvastatin, Probucol, Blood lipids, Medicine, Acute coronary syndrome, Internal medicine, Pharmacology, Cholesterol

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Effect of Probucol and Atorvastatin on Success Rate of Blood Lipids and Prognosis in Acute Coronary Syndrome Patients — Research Paper | ScholarLens